A COVID-19 lockdown in China is causing a shortage of lidocaine and could lead to delayed dental procedures in the U.S., wral.com reported June 21.
Three things to know:
- The lockdown in China, which has affected manufacturers, combined with supply chain issues with Pfizer, a big producer of the drug, are causing nationwide shortages, including over-the-counter medications containing lidocaine.
- The shortage is causing providers to conserve their supply of the painkiller and cancel surgeries.
- Hospital administrators told the news outlet the shortage may not be resolved until next year but they are working to find alternatives.